External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population

References

• Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63:402–407. doi:10.1136/thx.2007.08545618234906
   PubMed Web of Science ®Google Scholar
• Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–985. doi:10.1378/chest.14-253525950276
   PubMed Web of Science ®Google Scholar
• Casas Herrera A, Montes de Oca M, López Varela MV, Aguirre C, Schiavi E, Jardim JR. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA study. PLoS One. 2016;11(4):e0152266. doi:10.1371/journal.pone.015226627073880
   PubMed Web of Science ®Google Scholar
• Llordés M, Jaén A, Almagro P, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. COPD. 2015;12(4):404–412. doi:10.3109/15412555.2014.97473625474184
   PubMedGoogle Scholar
• Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–868. doi:10.1136/thx.2009.11350619553233
   PubMed Web of Science ®Google Scholar
• Martinez CH, Mannino DM, Jaimes FA, et al. Undiagnosed obstructive lung disease in the United States. Associated factors and long-term mortality. Ann Am Thorac Soc. 2015;12(12):1788–1795. doi:10.1513/AnnalsATS.201506-388OC26524488
   PubMed Web of Science ®Google Scholar
• Labonté LE, Tan WC, Li PZ, et al. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use. Data from the CanCOLD study. Am J Respir Crit Care Med. 2016;194(3):285–298. doi:10.1164/rccm.201509-1795OC26836958
   PubMed Web of Science ®Google Scholar
• Gershon AS, Thiruchelvam D, Chapman KR, et al. Health services burden of undiagnosed and overdiagnosed COPD. Chest. 2018;153(6):1336–1346. doi:10.1016/j.chest.2018.01.03829425675
   PubMed Web of Science ®Google Scholar
• Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3):285–295. doi:10.1159/00009014216330875
   PubMed Web of Science ®Google Scholar
• Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med. 2010;104(8):1160–1170. doi:10.1016/j.rmed.2010.02.00920226647
   PubMed Web of Science ®Google Scholar
• Yawn BP, Mapel DW, Mannino DM, et al. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulm Dis. 2010;5:1–10.
   PubMedGoogle Scholar
• Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85–95. doi:10.1080/1541255080194072118415807
   PubMedGoogle Scholar
• Guirguis-Blake JM, Senger CA, Webber EM, Mularski RA, Whitlock EP. Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US preventive services task force. JAMA. 2016;315(13):1378–1393. doi:10.1001/jama.2016.265427046366
   PubMed Web of Science ®Google Scholar
• López Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V. Opportunistic COPD case-finding in primary care of four Latin America countries. Developing a simple screening tool: the PUMA study. Respirology. 2016;21(7):1227–1234. doi:10.1111/resp.1283427319305
   PubMed Web of Science ®Google Scholar
• Menezes AM, Perez-Padilla R, Jardim J, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875–1881. doi:10.1016/S0140-6736(05)67528-916310554
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0150WS28128970
   PubMed Web of Science ®Google Scholar
• Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6):1531–1539. doi:10.1378/chest.129.6.1531.16778271
   PubMed Web of Science ®Google Scholar
• Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J. 2011;20(2):184–189. doi:10.4104/pcrj.2011.0003821597666
   PubMedGoogle Scholar
• Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J. 2011;20(2):190–198. doi:10.4104/pcrj.2011.0004021597667
   PubMedGoogle Scholar
• Stanley AJ, Hasan I, Crockett AJ, van Schayck OC, Zwar NA. Validation of the COPD diagnostic questionnaire in an Australian general practice cohort: a cross-sectional study. Prim Care Respir J. 2014;23(1):92–97. doi:10.4104/pcrj.2014.0001524570082
   PubMedGoogle Scholar
• Dirven JA, Tange HJ, Muris JW, van Haaren KM, Vink G, van Schayck OC. Early detection of COPD in general practice: implementation, workload and socioeconomic status. A mixed methods observational study. Prim Care Respir J. 2013;22(3):338–343. doi:10.4104/pcrj.2013.0007123966213
   PubMedGoogle Scholar
• Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J. 2008;31(2):298–303. doi:10.1183/09031936.0007430717959636
   PubMed Web of Science ®Google Scholar
• Mintz ML, Yawn BP, Mannino DM, et al. Prevalence of airway obstruction assessed by lung function questionnaire. Mayo Clin Proc. 2011;86(5):375–381. doi:10.4065/mcp.2010.078721531880
   PubMed Web of Science ®Google Scholar
• Tsukuya G, Matsumoto K, Fukuyama S, et al. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study. Allergol Int. 2015;64(1):49–53. doi:10.1016/j.alit.2014.06.00225572558
   PubMed Web of Science ®Google Scholar